Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis

Endocrine Journal

Volumn 60, Issue 10, 2013, Pages 1155-1164

  Kajitani, Takashi ^a   Maruyama, Tetsuo ^a   Asada, Hironori ^a   Uchida, Hiroshi ^a   Oda, Hideyuki ^a   Uchida, Sayaka ^a   Miyazaki, Kaoru ^a   Arase, Toru ^a   Ono, Masanori ^a   Yoshimura, Yasunori ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Dysmenorrhea; Dyspareunia; Endometriosis; Nerve growth factor

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PELVIC PAIN; PERITONEAL FLUID; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; ASCITIC FLUID; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; HUMANS; NERVE GROWTH FACTOR; PELVIC PAIN; UP-REGULATION;

EID: 84887014599     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0027     Document Type: Article

References (38)

1. Giudice LC, Kao LC (2004) Endometriosis. Lancet 364: 1789-1799.
2. Kuohung W, Jones GL, Vitonis AF, Cramer DW, Kennedy SH, et al. (2002) Characteristics of patients with endometriosis in the United States and the United Kingdom. Fertil Steril 78: 767-772.
3. Berkley KJ, Rapkin AJ, Papka RE (2005) The pains of endometriosis. Science 308: 1587-1589.
4. Wu MH, Shoji Y, Chuang PC, Tsai SJ (2007) Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 9: 1-20.
5. Abu JI, Konje JC (2000) Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update 6: 200-205.
6. Surrey ES (2006) The role of progestins in treating the pain of endometriosis. J Minim Invasive Gynecol 13: 528-534.
7. Batzer FR (2006) GnRH analogs: options for endometriosis-associated pain treatment. J Minim Invasive Gynecol 13: 539-545.
8. Adamson GD (2006) Control of chronic pelvic pain. J Minim Invasive Gynecol 13: 578-582.
9. Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29: 507-538.
10. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS (1994) Neurotrophic factors: from molecule to man. Trends Neurosci 17: 182-190.
11. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, et al. (1995) Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 147: 309-324.
12. Bayas A, Kruse N, Moriabadi NF, Weber F, Hummel V, et al. (2003) Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells. Neurosci Lett 335: 155-158.
13. Otten U, Scully JL, Ehrhard PB, Gadient RA (1994) Neurotrophins: signals between the nervous and immune systems. Prog Brain Res 103: 293-305.
14. Dolle L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H (2003) Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 22: 5592-5601.
15. Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, et al. (2001) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 276: 17864-17870.
16. Shu XQ, Mendell LM (1999) Neurotrophins and hyperalgesia. Proc Natl Acad Sci U S A 96: 7693-7696.
17. Koltzenburg M (1999) The changing sensitivity in the life of the nociceptor. Pain Suppl 6: S93-102.
18. Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE, et al. (2005) A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res 65: 9426-9435.
19. Anaf V, Simon P, El Nakadi I, Fayt I, Simonart T, et al. (2002) Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 17: 1895-1900.
20. Tokushige N, Markham R, Russell P, Fraser IS (2006) Nerve fibres in peritoneal endometriosis. Hum Reprod 21: 3001-3007.
21. Akobeng AK (2007) Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 96: 644-647.
22. Odagiri K, Konno R, Fujiwara H, Netsu S, Yang C, et al. (2009) Smooth muscle metaplasia and innervation in interstitium of endometriotic lesions related to pain. Fertil Steril 92: 1525-1531.
23. Zhang G, Dmitrieva N, Liu Y, McGinty KA, Berkley KJ (2008) Endometriosis as a neurovascular condition: estrous variations in innervation, vascularization, and growth factor content of ectopic endometrial cysts in the rat. Am J Physiol Regul Integr Comp Physiol 294: R162-171.
24. Colangelo AM, Johnson PF, Mocchetti I (1998) betaadrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta. Proc Natl Acad Sci U S A 95: 10920-10925.
25. McCauslin CS, Heath V, Colangelo AM, Malik R, Lee S, et al. (2006) CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system. J Biol Chem 281: 17681-17688.
26. Colangelo AM, Mallei A, Johnson PF, Mocchetti I (2004) Synergistic effect of dexamethasone and betaadrenergic receptor agonists on the nerve growth factor gene transcription. Brain Res Mol Brain Res 124: 97-104.
27. Cartwright M, Martin S, D'Mello S, Heinrich G (1992) The human nerve growth factor gene: structure of the promoter region and expression in L929 fibroblasts. Brain Res Mol Brain Res 15: 67-75.
28. Zheng M, Heinrich G (1988) Structural and functional analysis of the promoter region of the nerve growth factor gene. Brain Res 427: 133-140.
29. Attar E, Bulun SE (2006) Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update 12: 49-56.
30. Gadient RA, Cron KC, Otten U (1990) Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 117: 335-340.
31. Wang G, Tokushige N, Markham R, Fraser IS (2009) Rich innervation of deep infiltrating endometriosis. Hum Reprod 24: 827-834.
32. Berkley KJ, Dmitrieva N, Curtis KS, Papka RE (2004) Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci U S A 101: 11094-11098.
33. Apfel SC (2000) Neurotrophic factors and pain. Clin J Pain 16: S7-11.
34. Lewin GR, Ritter AM, Mendell LM (1993) Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13: 2136-2148.
35. Sarchielli P, Alberti A, Floridi A, Gallai V (2001) Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 57: 132-134.
36. Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, et al. (2006) Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 27: 85-91.
37. Klein R (1994) Role of neurotrophins in mouse neuronal development. FASEB J 8: 738-744.
38. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, et al. (1994) Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 91: 3739-3743.